Resources

OncoTarget® 500 is a comprehensive genomic profiling panel that analyzes over 500 genes to detect genomic alterations known to alter cancer growth. It provides physicians and researchers with medically actionable anlyses on hundreds of cancer-related gene.

OncoTarget provides physicians and researchers with medically actionable analyses on hundreds of cancer-related genes to help determine the specific genomic profile of an individual tumor.

With OncoTracking, signs of recurrence can be identified sooner than traditional screening tools. OncoTracking is a highly sensitive monitoring tool that utilizes liquid biopsy to screen for circulating tumor DNA (ctDNA), which is indicative of cancer recurrence and can be found before the recurrence is detectable on imaging.

Customized research and analysis that transforms information on clinical trials, drugs, and sites into actionable intelligence for your organization.